Product Overview
POULMMUNE™ SALMONELLA BCD is an inactivated tetravalent water-in-oil (W/O) emulsified vaccine against key Salmonella serovars: S. Enteritidis, S. Typhimurium, S. Kentucky and S. Gallinarum.
You are viewing South Asia
POULMMUNE™ SALMONELLA BCD
POULMMUNE™ SALMONELLA BCD is an inactivated tetravalent water-in-oil (W/O) emulsified vaccine against key Salmonella serovars: S. Enteritidis, S. Typhimurium, S. Kentucky and S. Gallinarum.
Chickens.
Since decades, Salmonellosis remains a significant threat for public health across all continents worldwide. The ubiquitous nature of Salmonella allows these microorganism to survive and adapt to various environments, including animal, human, and non-animal hosts. Therefore, Salmonella control has been historically a major challenge for producers and regulators across the farm-to-fork food supply chain.1
In this context, Salmonella prevention programs in poultry are designed to i) avoid that hatching eggs, day-old chicks, and pullets become infected in primary production; and ii) prevent that feed, water, poultry facilities, rodents and fomites become the source of infection for those non-infected poultry flocks. 2
Considering the above, the poultry industry needs to invest in integrated risk management programs, including vaccines technologies capable to i) prevent the intestinal colonization, ii) minimize systemic dissemination and invasion of reproductive tract, and iii) reduce faecal shedding and egg shell contamination.2
Active immunization of chicken to reduce mortality and clinical signs associated with Salmonellosis caused by the 4 mentioned strains.
Birds can be vaccinated from 2 weeks of age onwards. Breeder and layer birds shall be vaccinated at least twice with 6 weeks interval. The most suitable vaccination program shall be consulted with your poultry veterinarian according to the local epidemiological situation.
Zero days.
The vaccine dose (0.5 mL/bird) should be administered subcutaneously in the lower part of the neck or intramuscularly into the chest muscles.
Before use, the vaccine should be shaken well to ensure proper mixing. Sterile injection equipment should be used to avoid contamination.
The vaccine may occasionally separate into two layers on storage. This in no way affects its potency, but the vaccine should be shaken vigorously before and during use to ensure good emulsification. Do not use POULMMUNE™ SALMONELLA BCD if you notice critical irreversible separation of the emulsion.
POULMMUNE™ SALMONELLA BCD is packed and presented in 500 mL (1000 doses) polyethylene terephthalate (PET) bottles.
References
1. Teklemariam, A. et. al. (2023). Human Salmonellosis: A Continuous Global Threat in the Farm-to-Fork Food Safety Continuum. Foods 2023, 12, 1756. https://doi.org/10.3390/foods12091756.
2. Ulrich Methner (2010). Vaccination of poultry against Salmonella: what is the ideal vaccine (strain)?. Friedrich-Loeffler-Institute, Federal Institute for Animal Health, Jena Branch, Naumburger Str.96a, D-07743 Jena, Germany.
Fill out the form below to connect with Kemin's vaccine experts
The content on this site is intended for informational purposes only and is not intended to be a substitute for professional veterinary advice. Although the information on this site is accessible worldwide, not all products or services are available to all persons or in all geographic locations or jurisdictions. Certain statements, product labeling and claims may differ by geography or as required by local governmental regulations.
© Kemin Industries, Inc. and its group of companies all rights reserved. ® ™ Trademarks of Kemin Industries, Inc., USA
Certain statements may not be applicable in all geographical regions. Product labeling and associated claims may differ based upon government requirements